160
Participants
Start Date
January 1, 2026
Primary Completion Date
November 1, 2026
Study Completion Date
December 1, 2026
hypoglycemic treatment
"The diabetes management adheres to the The 2025 Guidelines for Standards of Diabetes Care issued by the American Diabetes Association (ADA)."
Tangshen'an Granules
Tangshen'an Granules comprises a meticulously blended mix of Astragalus, Prepared Rehmannia Root, Dodder Seed, Kudzu Root, Millettia Speciosa Champ, Salviae Miltiorrhizae Radix et Rhizoma, Poria Cocos, and Polygala Tenuifolia. Tangshen'an Granules is administered at a dosage of 9g, dissolved in boiling water, and taken three times daily.
Ginkgo Leaf Tablets
The primary active ingredients of Ginkgo Leaf Tablets are ginkgo flavonoid glycosides and terpene lactones. The prescribed oral dosage is one tablet each time, administered three times a day.
Mecobalamin Tablets
Mecobalamin Tablets primarily contain mecobalamin, which is a coenzyme-active form of vitamin B12. The prescribed oral dosage is 0.5mg, administered three times a day.
placebo
The placebo contains 10% of the active ingredients in Tangshen'an Granules, formulated by controlling the concentration to mimic Tangshen'an Granules. The placebo is administered at a dosage of 9g, dissolved in boiling water, and taken three times daily.
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu
Deyang Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Deyang
Guangyuan North Sichuan Diabetes Specialty Hospital, Guangyuan
Hejiang Ye
OTHER